ProQR Therapeutics N.V. buy blaugold
Start price
30.03.23
/
50%
€1.82
Target price
30.03.24
-
Performance (%)
-2.03%
End price
14.05.23
€1.78
Summary
This prediction ended on 14.05.23 with a price of €1.78. With a performance of -2.03%, the BUY prediction by blaugold finished with a loss. blaugold has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
ProQR Therapeutics N.V. | -4.013% | -4.013% | 22.964% |
iShares Core DAX® | 1.937% | 1.473% | 18.596% |
iShares Nasdaq 100 | -1.186% | -0.040% | 27.123% |
iShares Nikkei 225® | 1.938% | 4.205% | 17.502% |
iShares S&P 500 | -0.023% | 0.109% | 24.843% |
According to blaugold what are the pros and cons of ProQR Therapeutics N.V. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by blaugold for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
Buy ProQR Therapeutics N.V.
In the thread Trading ProQR Therapeutics N.V.
Buy beendet
Stopped prediction by blaugold for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.67
21.01.24
21.01.24
-
21.01.25
21.01.25
18.80%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year